The Challenge of Efflux-Mediated Antibiotic Resistance in Gram- Negative Bacteria

The Challenge of Efflux-Mediated Antibiotic Resistance in Gram- Negative Bacteria

crossmark The Challenge of Efflux-Mediated Antibiotic Resistance in Gram- Negative Bacteria Downloaded from Xian-Zhi Li,a Patrick Plésiat,b Hiroshi Nikaidoc Human Safety Division, Veterinary Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa, Ontario, Canadaa; Laboratoire de Bactériologie, Faculté de Médecine-Pharmacie, Centre Hospitalier Régional Universitaire, Université de Franche-Comté, Besançon, Franceb; Department of Molecular and Cell Biology, University of California, Berkeley, California, USAc SUMMARY ..................................................................................................................................................338 http://cmr.asm.org/ INTRODUCTION ............................................................................................................................................339 BIOCHEMISTRY AND GENETICS OF MULTIDRUG EFFLUX PUMPS ........................................................................................339 Classes of Efflux Pumps...................................................................................................................................339 RND Transporters ........................................................................................................................................340 AcrB of Escherichia coli .................................................................................................................................340 Other RND transporters in E. coli .......................................................................................................................347 MFS Transporters .........................................................................................................................................347 ABC Transporters .........................................................................................................................................348 SMR Transporters.........................................................................................................................................348 MATE Transporters .......................................................................................................................................349 on March 24, 2015 by Univ of California-Berkeley Biosci & Natural Res Lib SYNERGY WITH THE OUTER MEMBRANE BARRIER ........................................................................................................349 Pathways of Drug Influx across the OM ..................................................................................................................349 Drugs Traversing the OM Mainly through Porin Channels ...............................................................................................350 Drugs Traversing the OM through the Lipid Bilayer Region ..............................................................................................351 GAMMAPROTEOBACTERIA: ENTEROBACTERIACEAE .......................................................................................................351 E. coli......................................................................................................................................................351 Fluoroquinolones......................................................................................................................................352 ␤-Lactams .............................................................................................................................................352 Other drugs............................................................................................................................................353 Salmonella spp. ..........................................................................................................................................353 Citrobacter spp. ...........................................................................................................................................353 Enterobacter aerogenes and Enterobacter cloacae.........................................................................................................354 Klebsiella pneumoniae ....................................................................................................................................354 Proteus, Providencia, and Morganella spp. ................................................................................................................356 Serratia marcescens .......................................................................................................................................356 Shigella flexneri............................................................................................................................................356 Yersinia enterocolitica and Yersinia pestis..................................................................................................................356 OTHER GAMMAPROTEOBACTERIA: VIBRIO, AEROMONAS, LEGIONELLA, AND PASTEURELLACEAE .......................................................357 Vibrio spp. ................................................................................................................................................357 Aeromonas spp. ..........................................................................................................................................357 Legionella spp. ...........................................................................................................................................357 Pasteurellaceae ...........................................................................................................................................358 Pasteurella multocida...................................................................................................................................358 Haemophilus influenzae ................................................................................................................................358 GAMMAPROTEOBACTERIA: PSEUDOMONAS, ACINETOBACTER, AND STENOTROPHOMONAS............................................................358 Pseudomonas aeruginosa .................................................................................................................................358 OM permeability.......................................................................................................................................358 RND efflux pumps. ....................................................................................................................................358 (continued) Published 18 March 2015 Citation Li X-Z, Plésiat P, Nikaido H. 18 March 2015. The challenge of efflux- mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev doi:10.1128/CMR.00117-14. Address correspondence to Hiroshi Nikaido, [email protected]. Copyright © 2015, American Society for Microbiology. All Rights Reserved. doi:10.1128/CMR.00117-14 April 2015 Volume 28 Number 2 Clinical Microbiology Reviews cmr.asm.org 337 Li et al. (i) MexAB-OprM .....................................................................................................................................358 (ii) MexXY-OprM(OprA)..............................................................................................................................359 (iii) MexCD-OprJ.....................................................................................................................................360 (iv) MexEF-OprN.....................................................................................................................................361 (v) Other RND pumps ...............................................................................................................................361 Downloaded from Acinetobacter spp. ........................................................................................................................................361 OM permeability.......................................................................................................................................361 RND efflux pumps .....................................................................................................................................362 Non-RND efflux pumps ................................................................................................................................362 Stenotrophomonas maltophilia ...........................................................................................................................363 ALPHAPROTEOBACTERIA: BRUCELLA, BARTONELLA, AND RICKETTSIA ....................................................................................363 Brucella spp. ..............................................................................................................................................364 Bartonella spp. ...........................................................................................................................................364 Rickettsia spp. ............................................................................................................................................364 BETAPROTEOBACTERIA: ACHROMOBACTER, BURKHOLDERIA, AND NEISSERIA ...........................................................................364 http://cmr.asm.org/ Achromobacter spp. ......................................................................................................................................364

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    82 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us